PubMed:15987957 / 0-161
Annnotations
Glycan-Motif
{"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":43,"end":62},"obj":"https://glytoucan.org/Structures/Glycans/G64581RP"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
GlyCosmos6-Glycan-Motif-Image
{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":43,"end":62},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
GlyCosmos6-Glycan-Motif-Structure
{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":43,"end":62},"obj":"https://glytoucan.org/Structures/Glycans/G64581RP"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
GlycoBiology-GDGDB
{"project":"GlycoBiology-GDGDB","denotations":[{"id":"_T17","span":{"begin":126,"end":160},"obj":"http://acgg.asia/db/diseases/gdgdb?con_ui=CON00385"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
ICD10
{"project":"ICD10","denotations":[{"id":"T1","span":{"begin":152,"end":160},"obj":"http://purl.bioontology.org/ontology/ICD10/G72.9"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":63,"end":80},"obj":"http://www.uniprot.org/uniprot/P51606"},{"id":"T2","span":{"begin":79,"end":105},"obj":"http://www.uniprot.org/uniprot/F5H499"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
uniprot-mouse
{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":79,"end":105},"obj":"http://www.uniprot.org/uniprot/Q91WG8"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":79,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0009384"},{"id":"T2","span":{"begin":99,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0033674"},{"id":"T3","span":{"begin":99,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0016301"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":9,"end":13},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T8","span":{"begin":137,"end":151},"obj":"http://purl.obolibrary.org/obo/GO_0016234"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
EDAM-topics
{"project":"EDAM-topics","denotations":[{"id":"T1","span":{"begin":120,"end":125},"obj":"http://edamontology.org/topic_2815"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
NGLY1-deficiency
{"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T1","span":{"begin":43,"end":62},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":126,"end":160},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0007827"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
HP-phenotype
{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":152,"end":160},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0003198"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}
NCBITAXON
{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":120,"end":125},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy."}